Average Co-Inventor Count = 9.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Netherlands Cancer Institute (4 from 8 patents)
2. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
3. Rosetta Inpharmatics, Inc. (2 from 47 patents)
4. Peter S. Linsley (0 patent)
5. Yudong He (0 patent)
6. Mao Mao (0 patent)
7. Christopher J. Roberts (0 patent)
8. Hongyue Dai (0 patent)
9. Van De Vijver, Marc J. (0 patent)
10. Van't Veer, Laura Johanna (0 patent)
11. Rene Bernards (0 patent)
12. A. A. M. Hart (0 patent)
13. Laura Johanna Van't Veer (0 patent)
14. Marc J. Van De Vijver (0 patent)
4 patents:
1. 9909185 - Diagnosis and prognosis of breast cancer patients
2. 7863001 - Diagnosis and prognosis of breast cancer patients
3. 7514209 - Diagnosis and prognosis of breast cancer patients
4. 7171311 - Methods of assigning treatment to breast cancer patients